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Abstract 
Some aspects of a defense against an oxidative stress are reviewed. All these aspects are focused on the necessity to defend mtDNA 
against damage. Protecting mechanisms involve the regulation of mitochondrial transport of nucleic acids, and the development of 
antioxygen defense as preventive measures. In the first case an exclusive role is supposed to play the mitochondrial benzodiazepine 
receptor and components, regulating the activity of its participants (mitochondrial porin and adenine nucleotide translocator). The possible 
transport of nucleic acids through Ca2+-dependent permeability transition pore, representing one of the functional states of mitochondrial 
benzodiazepine receptor, is put forth. Such mechanisms can also cover the genomic nuclear-mitochondrial exchange. The second aspect 
reviews the possible complex of measures to lower the harmful effect of oxygen. Among these measures are mild uncoupling, the opening 
of a permeability transition pore and cellular apoptosis as was recently suggested by Skulachev. Problems uch as cellular aging and 
mitochondrial diseases, are discussed in light of the relevance to the problem of oxidative stress. 
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1. Introduction 
The proven existence of two cellular pools of DNA 
raises many questions about the different roles played by 
cell nuclear and mitochondrial genetic material. Accumu- 
lated information in recent years showing increasing inter- 
action of these intracellular DNA pools cannot be ignored 
and a comprehensive hypothesis explaining this interaction 
has yet to be proposed. 
We have to admit that recent introduction and wide use 
of the term 'programmed cellular death' put some base for 
considering mitochondria s a control unit and some sort 
of biological clock with their own 'molecular clock' [1]. 
According to the latter, the mitochondrion can be regarded 
as a measuring device which keeps track of the temporal 
changes within a cell and the quantitative measures of their 
ticks are mutations in mtDNA. All these speculations 
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result from the idea that mitochondria play an exclusive 
role in cellular aging and age-associated degenerative dis- 
eases. Basically these ideas arouse from the free radical 
theory of aging [2], or put differently, mitochondrial theory 
of aging. 
2. Hypothetical mitochondrial exchange with nucleic 
acids 
It is widely recognized that the mitochondrial function 
is that of oxidizing the cell substrates, thus producing a 
proton electrochemical potential and finally ATP. Very 
aggressive oxidative activity of mitochondria requires the 
proper protection of all intramitochondrial systems from 
being damaged. In spite of sophisticated defense (through 
the high activity of the enzymes trapping the radicals and 
highly reactive molecules) oxidative damage still does 
occur. Both for membranes and mtDNA the consequences 
of the resulting reactive oxygen species attack can be fatal. 
The very high mutation rate of mtDNA (at least 10-times 
higher than in nuclear genome, including point mutation, 
deletion, insertion and depletion) is likely associated with 
more than one-hundred mitochondrial diseases, like my- 
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opathy, cardiomyopathy, encephalopathy, lactic acidosis, 
stroke-like episodes, epilepsy and many others. A new 
term 'mitochondrial medicine' has been introduced [3], 
commensurate with the importance of normal mitochon- 
drial homeostasis n the maintenance of cellular functions. 
It has been suggested [4] that the DNA repair repertoire, 
which is less organized in mitochondria [5] than in the 
nuclei, is likely the source of at least some biologic 
dysfunction. The progression of mtDNA alterations is 
thought to be an aging process and when sufficiently 
advanced, the mtDNA mutations may result in cellular 
death. 
There is an obvious intrinsic discrepancy. From one 
side, the aggressive intramitochondrial media makes 
mtDNA damage more probable and, from another, the 
mechanism of mtDNA repair is not as perfect as that in the 
nucleus. One may conclude that the frequency of mito- 
chondrial mutations hould be much higher than of nuclear 
DNA. If mitochondrial DNA is responsible for the aging 
process, the existing discrepancy must be revealed by a 
linear regression i  terms of aging process and mortality of 
aging and diseases. The exponential nature of the mortality 
curve [6] apparently prompts that multiple reasons con- 
tribute to the aging as well as to mortality processes. 
One can hypothesize that the relatively limited ability to 
repair the mtDNA lesions can be compensated for (or, on 
the other hand, be amplified) by equilibration of mitochon- 
drial genetic material through its intermitochondrial ex- 
change [7]. Analogous mechanisms are already well known 
in bacteria, where a general mechanism of the nucleic 
acids (NA) transport through bacterial membranes (during 
genetic transformation, transfection, viral infection and 
bacterial conjugation) has been described (for review, see 
[8]). The driving force for bacterial NA transport is postu- 
lated to be the proton electrochemical potential gradient 
(minus inside) [9]. Nucleic acids - which have a net 
negative charge - tend to leave the host cell and are 
transferred into extracellular medium or into the neighbor- 
ing bacteria through the channels formed by tiny junctions 
(piles) between the cells. In case of conjugating bacteria 
the NA recipient would need to have lower membrane 
potential than that of the donor's cell to enable the trans- 
port. 
There are numerous indirect observations supporting the 
idea of mitochondrial NA transport. Part of human mito- 
chondrial DNA was found in the nuclear genome [10] 
(with the ability for autonomous replication [11]), as well 
as nuclear-encoded bovine 5S-rRNA [12] or mouse MPR 
RNA (mitochondrial RNA-processing endoribonuclease) 
were found in mitochondria [13] and other examples of 
nucleomitochondrial transport of NA. In this row is the 
recent finding of the fast dispersal of mitochondrial genetic 
material among the whole mitochondrial population, which 
is of fundamental importance [14]. The conclusion that the 
intermitochondrial exchange of their DNA (mtDNA) is a 
rapid, dynamic process is thus of prime importance. 
The escape of DNA from yeast mitochondria has been 
described in detail [15]. A remarkable aspect of this was 
that the traffic from mitochondrion to nucleus was surpris- 
ingly high, but traffic in the opposite direction at least 
100000-fold less frequent. This supports the suggestion 
that the mitochondrial membrane potential may govern the 
process responsible for the apparently preferable unidirec- 
tional transport of negatively charged species outward 
from the mitochondria. 
All mitochondrial channels described are probably too 
small to permit nucleoproteins transport hrough them 
without changing conformation of either the channel or 
NA. These are: 107 pS anion channel, MCC 1.3 nS 
megachannel, ATP-sensitive channel and low-conductance 
alkaline-induced channel in the inner membrane (for re- 
view see [16]). A much larger channel has been described 
in heart mitoplasts (up to 3.2 nS in 0.15 mM KC1) [17]. 
The outer mitochondrial membrane contains the only volt- 
age dependent anion channel (mitochondrial porin, which 
in some features resembles the porin of the outer bacterial 
membrane). 
It deserves to be specially considered the phenomenon 
of generation in mitochondria of so-called permeability 
transition pore (PTP) a water-filled channel with the size 
when up to 1.3 kDa molecules can go through. PTP can be 
induced by a number of factors with the obligatory partici- 
pation of calcium ions (for reference see [18]). PTP has a 
specific inhibitor-cyclosporine A, a well known immuno- 
suppressant. It is known to modulate its activity through 
the binding with a number of cyclosporine-binding pro- 
teins having the common name cyclophilins. Cyclophilins 
possess peptidyl-prolyl cis-trans-isomerase (rotamase) ac- 
tivity, implying their participation in three-dimensional 
organization of proteins. They are very abundant cellular 
proteins, having been found in cytosol, mitochondrial ma- 
trix and endoplasmic reticulum [19]. Cyclophilins were 
shown to be from the family of DNA-binding proteins 
(they can be released from DNA-containing affinity col- 
umn) [20] and possess nuclease activity [21]. 
It has been speculated that mitochondrial PTP is highly 
regulated by the conformation of mitochondrial adenine 
nucleotide translocator (ANT), through the binding of 
cyclophilin to ANT. According to the scheme of Halestrap 
and Davidson [22] cyclosporine A, while bound to cy- 
clophilin, removes it from ANT and the pore closes. 
Surprisingly, ANT has a high-affinity binding site for 
DNA [23]. Not only ANT, but all other members of the 
family of mitochondrial carriers have this knuckle - i.e., 
possess DNA-binding properties [24]. There is one more 
striking property of ANT, namely that it binds thyroid 
hormones with very high association constant of 2 X 1011 
M J [25]. This suggests ANT could act as a thyroid 
hormone receptor [26]. 
The particular ole in the process of mitochondrial 
transport of NA might play mitochondrial benzodiazepine 
receptor (MBR) [7]. The MBR is shown to be a multipro- 
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tein complex, consisting of an actual receptor 18 kDa 
subunit and two regulatory units, namely, mitochondrial 
porin and ANT [27]. Mitochondrial channel activity can be 
modulated by benzodiazepines, consistent with the idea 
that MBR is a mitochondrial channel [28]. If you add data, 
showing that the mitochondrial megachannel could be 
blocked by cyclosporine A [29], it seems to be clear that 
PTP is the functional state of MBR. 
Thus multiple lines of evidence demonstrate hat mito- 
chondria possess all the necessary attributes for controlled 
machinery of NA transport: they have NA-binding pro- 
teins, transmembrane channels and potential sites of hor- 
monal regulation. These features all potentially exist within 
the single structure MBR/PTP. Recent data show that the 
state of MBR/PTP determines the retention of added 
plasmid DNA by isolated mitochondria, as well as the 
release of mtDNA into incubation medium [30]. 
In discussing the possibility of mitochondrial transmem- 
brane transport of NA one should not forget hat mitochon- 
dria are very dynamic structures and able to exchange their 
content hrough the process of constant mitochondrial fis- 
sion and fusion (where it takes place). In those cells, where 
ordered content does not permit intracellular mitochondrial 
motions (for example, in striated muscle) mitochondria 
might have some special features to enable intermitochon- 
drial communications. They may be referred to intermito- 
chondrial junctions, existing in striated muscle cells [31]. 
These intermitochondrial junctions were shown to be elec- 
trically permeable [32] and enriched with mitochondrial 
porin [33]. By the way, joining heart mitochondria within 
cardiomyocytes resemble conjugating bacterial cells [31,34] 
(Fig. 1), where the transfer of genetic material is well 
known. 
It is clear, that understanding of the mechanisms of 
mitochondrial transmembrane transport of nucleic acids 
would help in directed repair of a damaged mitochondrial 
genome. The attempts to develop this kind of strategy have 
been made [35,36], through creating of a chimeric 
molecules, combining both oligonucleotides and mitochon- 
drial protein signal sequences. Within this strategy, the 
machinery of the mitochondrial protein transport was in- 
tended to be use for the transfer of nucleic acids into 
mitochondria. At the same time, it is impossible to exclude 
that mitochondria possess their own transport machinery 
specific to oligonucleotides. This also seems to be the case 
for MRP RNA where the coding region has been deter- 
Fig. 1. Conjugational nd intermitochondrial junctions. Left side - electron microscopic serial sections through conjugation-specific junctions in E. coli 
(from [34] with permission); right side - serial sections through the intermitochondrial junctions from rat heart muscle (from [31] with permission). 
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mined, and in which partial deletion results in the loss of 
mitochondria as a target for RNA transport [37]. HIV RNA 
is apparently using the same mode of transfer into mito- 
chondria: 'by mistake' instead of MRP complex [38]. For 
both proteins and NA transport he participation of the 
same machinery with some modifications may be very 
possible. Recent data provide an evidence that for transport 
of nuclear-encoded RNA into yeast mitochondria, the en- 
ergy source and intact machinery for protein transport are 
required (MOM19, MPI I /MIM44 are necessary, although 
MOM72 is not) [39]. 
In a foregoing discussion we have already considered 
the necessity for 'protection' of mitochondrial genome 
from inevitable changes resulting in genomic mutation. 
The genome, if not properly repaired in time, can be the 
source of a number of mitochondrial diseases. Besides 
classical genome reparation, there are potentially some 
other ways to avoid such deleterious changes. One way 
may enable non-classical reparation through the possible 
NA exchange similar to that of bacteria. However, we 
cannot exclude the possibility, a priori, that such a NA 
exchange would actually result in the amplification of the 
genome damage through its spreading within the cell 
rather than serving to repair the damage. This idea finds a 
support from observations that mitochondrial DNA se- 
quences that insert into the nuclear genome contribute to 
cancer and aging [10]. 
3. Skulachev's model of an antioxygen defense 
Another way to limit a damage is by creating the 
conditions which limit the production of harmful oxygen 
intermediates. Fig. 2 schematically represents oxygen path- 
ways, thus giving a strategy for mitochondrial ntioxygen 
defense suggested by Skulachev [40]. 
One-electron reduction of oxygen in the respiratory 
chain results in the generation of superoxide anion radical, 
which beside of its own destructive properties, can induce 
the formation of even more destructive hydroxyl radicals. 
The last and other reactive oxygen species can induce lipid 
peroxidation, enzyme inactivation and DNA damage. 
Among these deleterious effects of oxygen, we choose and 
put on a scheme only mitochondrial DNA damage, which 
from our point of view is of prime importance. 
There are two principle ways to protect he cell from an 
oxygen lesion. The first way is to prevent he formation of 
reactive oxygen species, and the second is to destroy 
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Fig. 2. Antioxygen defense mechanisms in mitochondria (by Skulachev [40] with modifications; Dr. A.A. Starkov assisted). Deleterious effects represented 
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already formed harmful oxygen intermediates. Conven- 
tional four-electron reduction of oxygen results in the 
generation of electrochemical potential of hydrogen ions in 
mitochondria. A~n+ encircled in the scheme presented in 
Fig. 2 is used for ATP production and then for work. In 
State 4 the electron flow through the respiratory chain is 
low, and the rate of superoxide radical production is going 
up [41,42]. To redirect he process to the left of 0 2 , thus 
preventing the generation of reactive oxygen, the simplest 
way seems just to increase the load. Skulachev [40] sug- 
gests to induce a proton leak through the inner mitochon- 
drial membrane which will result in higher oxygen con- 
sumption and production lowering of the long-lived CoQ= 
level and, hence, of O~. Mild uncoupling (see block 1 in 
the scheme) is one of the ways to introduce a load to the 
system, thus discharging A~H+. 
One more way to give a load to the system is the 
activation of any kind of work supported by ATPase. The 
beneficial effect of a physical oad for recovery from many 
physiological disorders is well known. Here we can only 
mention the benefit of physical exercise for diabetic and 
elderly animals [43,44]. The mechanism of such a recovery 
may follow from the scheme (Fig. 2) according to which 
work will discharge the proton potential, thus making the 
oxygen danger less than when resting. 
Block 2 (pore) represents he induction in mitochondria 
of a permeability transition pore. As it mentioned above, 
FFP, being the functional state of MBR, might serve as a 
root for the transport of NA in mitochondria [7,30]. Ac- 
cording to Skulachev [40-42] mitochondrial PTP is the 
next step of antioxygen defense if the lesion is so severe 
that mild uncoupling is not enough to save a system from 
oxygen damage. 
PTP-induced collapse of the membrane potential (which 
regulates a number of cellular functions) might be one 
piece in a muitistep process of a programmed cellular 
death (apoptosis, represented by block 3 in Fig. 2) [17,18]. 
That is why PTP must have very precise regulation, not 
having to stay in an opened state longer than it is neces- 
sary for the recovery of mitochondrial functional proper- 
ties; otherwise it is possible to initiate the mechanism of a 
cellular death. In this case optimal seems to be the oscilla- 
tion of the mitochondrial membrane potential to prevent 
irreversible mitochondrial damage when the membrane 
potential has been lost for a long time. Definitely, it has 
some sense, if PTP has some physiological significance. 
By the way, aging, is shown to sensitize mitochondria 
to Ca2+-induced permeability transitions [45]. It may be 
that an aging process per se gives the signal that results in 
cellular death. If we discuss the aging phenomena in terms 
of mitochondrial changes, it becomes clear that mtDNA is 
constantly in conflict between the continual change of its 
16569 nucleotide bases (for humans) and the necessity to 
keep the genome constant (shown as block 4 in Fig. 2). 
This conflict might be solved by a reasonable quilibrium 
between the rates of base change and the repair process. 
The last definitely includes intramitochondrial endonucle- 
ases, which should work in a very precise manner: their 
moderate activity deletes mutations [46], and anything 
beyond this moderate rate could result in irreversible 
mtDNA fragmentation [47]. What does optimize the activ- 
ity of mitochondrial endonucleases? These enzymes are 
highly Mg 2+- and Ca~+-dependent, and their activity defi- 
nitely depends on the rate of oxidative phosphorylation 
[48]. We can only speculate that A/2H+ regulates the 
activity of mitochondrial endonucleases. 
We cannot bypass the problem of protection from oxy- 
gen damage by using antioxidants, or by avoiding to 
introduce into the living system the elements initiating 
free-radical reactions (cf. [6]). Part of this problem is 
definitely of a nutritional nature. The same defensive ffect 
can be achieved by the activation of radical scavengers - 
i.e., enzymes responsible for trapping oxygen intermedi- 
ates (shown accompanied by dashed lines in Fig. 2 as 
superoxide dismutase, SOD, catalase, and peroxidases). 
4. Conclusions 
We have attempted to summarize the main measures 
designated to save mtDNA from oxidative damage. With 
this purpose in mind, we highlighted four blocks in Fig. 2, 
which, from our point of view, are of strategic importance. 
The regulation of a defense mechanism, directed to protect 
mitochondrial integrity from oxygen lesions, is following 
from the scheme, where the individual regulation of any of 
highlighted blocks takes place. The hypothetical NA trans- 
fer between mitochondria which proceeds through partici- 
pation with a nucleus, potentially undermines the precise 
regulation of NA transfer. If it goes through MBR/PTP, 
all the factors determining the receptor's functional state 
can be involved. It seems to be that - at least in part - the 
participation of MBR/PTP, in all four problems is highly 
possible. 
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